Eleni M Rettig1, Carole Fakhry1,2, Russell K Hales3, Flora Kisuule4, Harry Quon1,3, Ana P Kiess3, Linda X Yin1, Yuehan Zhang2, Amanda L Blackford5, M Bradley Drummond4, Christine G Gourin1, Wayne M Koch1, David W Eisele1, Gypsyamber D'Souza1,2. 1. Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 3. Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland. 4. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland. 5. Department of Oncology, Division of Biostatistics and Bioinformatics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Abstract
BACKGROUND: Smoking among patients with cancer is associated with poor outcomes, however, smoking cessation interventions have had limited success. METHODS: This randomized controlled trial compared a novel smoking cessation intervention ("intervention") with enhanced usual care ("control"). Participants were smokers with head and neck or thoracic malignancies undergoing radiation. Controls received brief counseling. Intervention participants received intensive counseling, pharmacotherapy, text-messaging, and financial incentives. Biochemically confirmed 7-day abstinence at 8 weeks was compared using Fisher's exact t test. Smoking abstinence and intensity were also analyzed using time-series panel regression. RESULTS: The study population comprised 19 intervention and 10 control participants. More intervention (74%) than control (30%) participants abstained from smoking at 8 weeks (P = .05). Intervention participants were significantly more likely to abstain (adjusted odds ratio [OR] 14.70; 95% confidence interval [CI] 3.56-60.76) and smoked fewer cigarettes (adjusted incidence rate ratio [IRR], 0.16; 95% CI 0.06-0.40) during weeks 1 to 8. CONCLUSION: This intervention decreased smoking among patients with upper aerodigestive cancers during radiotherapy.
RCT Entities:
BACKGROUND: Smoking among patients with cancer is associated with poor outcomes, however, smoking cessation interventions have had limited success. METHODS: This randomized controlled trial compared a novel smoking cessation intervention ("intervention") with enhanced usual care ("control"). Participants were smokers with head and neck or thoracic malignancies undergoing radiation. Controls received brief counseling. Intervention participants received intensive counseling, pharmacotherapy, text-messaging, and financial incentives. Biochemically confirmed 7-day abstinence at 8 weeks was compared using Fisher's exact t test. Smoking abstinence and intensity were also analyzed using time-series panel regression. RESULTS: The study population comprised 19 intervention and 10 control participants. More intervention (74%) than control (30%) participants abstained from smoking at 8 weeks (P = .05). Intervention participants were significantly more likely to abstain (adjusted odds ratio [OR] 14.70; 95% confidence interval [CI] 3.56-60.76) and smoked fewer cigarettes (adjusted incidence rate ratio [IRR], 0.16; 95% CI 0.06-0.40) during weeks 1 to 8. CONCLUSION: This intervention decreased smoking among patients with upper aerodigestive cancers during radiotherapy.
Authors: George P Browman; E Ann Mohide; Andrew Willan; Ian Hodson; Gene Wong; Laval Grimard; Robert G MacKenzie; Samy El-Sayed; Edward Dunn; Sylvia Farrell Journal: Head Neck Date: 2002-12 Impact factor: 3.147
Authors: Adam O Goldstein; Carol E Ripley-Moffitt; Donald E Pathman; Katharine M Patsakham Journal: Nicotine Tob Res Date: 2012-04-11 Impact factor: 4.244
Authors: Robert A Schnoll; Elisa Martinez; Kristina L Tatum; Dorothy M Weber; Natalie Kuzla; Marcella Glass; John A Ridge; Corey Langer; Curtis Miyamoto; E Paul Wileyto; Frank Leone Journal: Cancer Causes Control Date: 2010-01-20 Impact factor: 2.506
Authors: Michael B Drummond; Jacquie Astemborski; Allison A Lambert; Scott Goldberg; Maxine L Stitzer; Christian A Merlo; Cynthia S Rand; Robert A Wise; Gregory D Kirk Journal: BMC Public Health Date: 2014-07-28 Impact factor: 3.295
Authors: Caitlin Notley; Sarah Gentry; Jonathan Livingstone-Banks; Linda Bauld; Rafael Perera; Jamie Hartmann-Boyce Journal: Cochrane Database Syst Rev Date: 2019-07-17
Authors: Alana M Rojewski; Lisa M Fucito; Nathaniel L Baker; Suchitra Krishnan-Sarin; Matthew J Carpenter; Steven L Bernstein; Benjamin A Toll Journal: Nicotine Tob Res Date: 2021-05-24 Impact factor: 4.244